ADA and ACC/AHA Guidelines for Improved LDL-Targeted Atheroprotection in Diabetic Patients: Unique Considerations and Target Goals in the Setting of T2D: What Works? How Well? What Doesn’t Work? How Low Should We Go? Why? - Vivian A. Fonseca, MD, FRCP - Program Co-Chair